From the very beginning, Volpara Solutions entered the healthcare space to help. In a very real sense, our job has been to support you, to help with your efforts to...
To understand the risk of developing a disease such as breast cancer, studies test the predictive value of risk factors.
Breast screening is rapidly moving into an era of personalized care, where prevention, early detection, and treatment are guided by risk assessment.
The need for greater participation in breast cancer screening programs cannot be overlooked. An estimated 1 in 8 women will develop breast cancer in her lifetime.
Katie Kaminski, MRT (R), is the lead mammography technologist for Mayfair Diagnostics in Alberta, Canada. Katie has been with Mayfair since 2012 and is responsible for maintaining Mayfair’s screening and...
The recommended frequency of breast cancer screening and the age at which a woman should begin mammography remain sources of considerable debate.
Last week, the United States’ Food and Drug Administration (FDA) agency proposed a rule that would inform women of their breast density.
We are very excited to share our newest white paper, Improved Surgical Outcomes and Breast Implant Selection, Application of Automated Volumetric Breast Measurements, authored by Drs. Monica Saini and Ariane Chan.
Dr. Cathrine Keller is the President and Managing Physician of Lake Medical Imaging, a full-service diagnostic imaging practice.
Volpara and image analysis developer ScreenPoint Medical have signed an MOU which will see the two companies seek to bring ScreenPoint’s artificial intelligence–based Transpara detection and decision support software to...